Name: Oleyl-PSar45
SKU: PSR1950
Availability: InStock

Gruppiert Produkte - Artikel

Anzahl

Verpackungsgröße

Preis

SKU

Warenverfügbarkeit

25 mg

290,00 €

PSR1950.0025

100 mg

1.000,00 €

PSR1950.0100

description

Nucleic acids have emerged in recent years as promising drug candidates for a wide range of diseases, as demonstrated by the development of mRNA vaccines to combat the Covid-19 pandemic. As nucleic acids are unable to pass physiological barriers, novel tools for packaging and delivery are required, especially since the frequently used polyethylene glycol may induce the generation of anti-PEG antibodies, leading to immunogenicity and allergic reactions. Iris Biotech offers a selection of innovative lipidated PSar and PGA-based polyamino acids for improved drug delivery.

SURPAX™ Technology (Surface Pacifying Excipient) was originally designed for protein stabilization but has found additional application as a shielding lipid in LNP formulations. This product shows superior properties for antibody and protein stability, does not impact binding, and maintains activities of mAB to targets. Biocompatibility has been tested vs body weight gain, vein tolerance, biochemical profile, and hematology.

references

US Patent 11,692,099

* Disclaimer

Wir verweisen auf unsere Allgemeinen Geschäftsbedingungen.
Alle Angaben in unserem Webshop sind nach bestem Wissen und Gewissen zusammengestellt.
Preise und Warenverfügbarkeiten können sich ändern und bedürfen einer Rückbestätigung. Für weitere Informationen kontaktieren Sie uns bitte.